Skip to main content

Table 1 C/T concentration variations measured using the ex vivo model

From: Influence of extracorporeal membrane oxygenation on the pharmacokinetics of ceftolozane/tazobactam: an ex vivo and in vivo study

Group

Ceftolozane

Tazobactam

8-h variation (%)

Dunnett test value

8-h variation (%)

Dunnett test value

Low concentration

 T0–T8

− 4.28

0.391

− 11.20

0.019

 T8–T16

− 2.63

0.433

− 12.95

0.524

 T16–T24

− 4.00

0.773

− 7.51

0.441

 Control

− 1.94

 

− 11.74

 

High concentration

 T0–T8

− 5.73

1.146

− 2.89

1.295

 T8–T16

− 3.99

1.147

− 6.75

0.340

 T16–T24

1.26

0.260

− 9.72

0.693

 Control

1.33

 

− 5.14

 
  1. Ceftolozane/tazobactam concentration variations measured in low and high concentration groups during the T0–T8, T8–T16 and T16–T24 inter-dose intervals and in the control glass tubes